Concord Biotech Limited — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Concord Biotech Limited has submitted a certificate from MUFG Intime India Pvt. Ltd., its Registrar and Share Transfer Agent, in accordance with SEBI regulations for the quarter ended March 31, 2025. This compliance action reaffirms the company's adherence to necessary procedural guidelines regarding share transfers.

For investors, this update signals operational stability and governance diligence, which may foster a positive outlook on the company's commitment to transparency and regulatory compliance. Overall, the announcement is likely to reassure shareholders about the management's focus on maintaining good standing within the market.